1-3 of 3
A Bastian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of Alternative Complement Pathway in Target Organs Represents a Novel and Effective Approach to Control Gvhd While Sparing GVL Effect

Hung D Nguyen, PhD, Ali Alawieh, MD PhDCandidate, David A Bastian, BS, Anusara Daenthanasanmak, PhD, Steven D Schutt, BS, Supinya Iamsawat, MSc, Yongxia Wu, PhD, Atkinson Carl, PhD, Stephen Tomlinson, PhD, Xue-Zhong Yu, PhD
Journal: Blood
Blood (2016) 128 (22): 807.
https://doi.org/10.1182/blood.V128.22.807.807
Published: 2016
Journal Articles

Prevention of Chronic Gvhd By Targeting Xbp-1 Genetically or Pharmacologically in Mice

Steven D Schutt, BS, Chih-Hang Anthony Tang, MD PhD, Yongxia Wu, PhD, David A Bastian, BS, Juan Del Valle, BS, PhD, Chih-Chi Andrew Hu, PhD, Xue-Zhong Yu, PhD
Journal: Blood
Blood (2016) 128 (22): 4541.
https://doi.org/10.1182/blood.V128.22.4541.4541
Published: 2016
Journal Articles

Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study

FM Foss, TA Borkowski, M Gilliom, M Stetler-Stevenson, ES Jaffe, WD Figg, A Tompkins, A Bastian, P Nylen, T Woodworth
Journal: Blood
Blood (1994) 84 (6): 1765–1774.
https://doi.org/10.1182/blood.V84.6.1765.1765
Published: 1994